merck & co. - Search News

News

Merck, vaccine and Robert F. Kennedy Jr.

Bloomberg on MSN · 2d

RFK Jr.’s New Vaccine Panel Includes Two Paid Witnesses Against Merck

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert witnesses for plaintiffs suing Merck & Co. over some of the drug company’s inoculations targeting measles,

RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit

Martin Kulldorff, appointed by RFK Jr. to a federal vaccine panel, previously earned $33K as an expert witness in lawsuits targeting Merck's Gardasil vaccine.

Reuters on MSN · 3d

Exclusive-Kennedy's new vaccine adviser was expert witness against Merck vaccine

By Chad Terhune and Dan Levine (Reuters) -One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck’s Gardasil vaccine,

10h

The Motley Fool: Merck’s risks and potential

There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...

11hon MSN

Goldman Sachs Remains a Buy on Merck & Co (MRK), Sets a $99.00 PT

Merck & Co., Inc. (NYSE:MRK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider from ...

Fierce Biotech6d

Merck's leader in oral PCSK9 inhibitor race reduces cholesterol in pair of phase 3 trials

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...

Fierce Pharma6d

Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus

One day before the potential FDA approval of a rival respiratory syncytial virus (RSV) monoclonal antibody from Merck & Co., ...

3d

Merck & Co. Inc. stock outperforms competitors on strong trading day

Merck & Co. Inc. closed 39.23% short of its 52-week high of $134.63, which the company reached on June 25th.

BioPharma Dive6d

Merck claims study success with PCSK9 cholesterol pill

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

6d

Merck Wins US Approval for Shot to Prevent Infant RSV

Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among ...

2don MSN

Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...

6d

Merck's Cholesterol Lowering Drug Hits Primary Goal In Two Pivotal Trials

Merck's oral PCSK9 inhibitor enlicitide showed significant LDL-C reductions in two Phase 3 trials, with no major safety ...

4d

Merck & Co. Inc. stock underperforms Wednesday when compared to competitors

The stock's fall snapped a three-day winning streak.

InvestorsHub on MSN3d

Merck Launches Final-Stage Trial of Dengue Vaccine for Children

Merck & Co Inc (NYSE:MRK) has begun a Phase 3 clinical trial to test its experimental dengue vaccine in a pediatric ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results